Study Strengthens Zika-GBS Link

Forty-one of 42 patients diagnosed with Guillain-Barré syndrome in French Polynesia had anti-Zika antibodies.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

PUBLIC HEALTH IMAGE LIBRARY, JAMES GATHANY

Of 42 Guillain-Barré syndrome patients examined in a recent case-control study led by investigators at Institut Louis Malardé in French Polynesia, 41 had anti-Zika antibodies, providing the strongest evidence yet for an association between the viral infection and the rare neurological disorder that can cause paralysis. “This is the first study providing evidence for Zika virus infection causing Guillain-Barré syndrome,” the study’s authors wrote in The Lancet this week (February 29).

Scientists last week (February 23) reported there was no strong link between Zika virus infection and Guillain-Barré syndrome among children studied in several Pacific countries.

For the present study, the researchers screened adult Guillain-Barré syndrome patients—aged 36 to 56—for antibodies against four types of dengue. This enabled them to separate the potential effects of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies